Compounded Semaglutide Composition

Last reviewed: May 31, 2026

Last updated: May 31, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Compounded semaglutide contains the active pharmaceutical ingredient semaglutide—a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist—combined with pharmaceutical-grade excipients selected to ensure sterility, stability, and proper delivery. Unlike branded versions manufactured by large pharmaceutical companies, compounded formulations are prepared in state-licensed 503A pharmacies under specific USP standards.

For patients considering compounded semaglutide, understanding what goes into each dose supports more informed conversations with healthcare providers. PlexusDx partners exclusively with licensed 503A compounding pharmacies to ensure quality oversight, and we believe transparency about formulation composition—combined with genetic insights into peptide pathway predispositions—can help you and your provider make personalized treatment choices.

Active Ingredient: Semaglutide and Its Mechanism

Semaglutide is a modified human glucagon-like peptide-1 analog with 94% amino acid sequence homology to native GLP-1. This synthetic peptide activates GLP-1 receptors throughout the body to regulate blood glucose, appetite signaling, and gastric emptying. It is the core therapeutic component in all semaglutide formulations, whether branded or compounded.

The semaglutide molecule is manufactured through recombinant DNA technology, producing a purified active ingredient that meets pharmacopeial standards. In compounded formulations prepared by licensed 503A pharmacies, this ingredient is sourced from qualified suppliers and combined with stabilizing agents to maintain potency and safety throughout its shelf life.

Excipients and Stabilizing Components in Compounded Formulations

Excipients are inactive ingredients that support the stability, delivery, and safety of semaglutide. Common excipients in compounded semaglutide injections include sodium phosphate dibasic, sodium phosphate monobasic, sodium chloride, and sterile water for injection. Each component serves a specific purpose: buffering pH, maintaining osmolarity, and ensuring sterility in multi-dose or single-dose vials.

Component	Function	Typical Role in Compounded Semaglutide
Semaglutide (active)	GLP-1 receptor agonism	Primary therapeutic agent; regulates glucose and appetite
Sodium phosphate buffer	pH stabilization	Maintains formulation pH between 7.0–7.4 for injection safety
Sodium chloride	Osmolarity balance	Ensures isotonicity to prevent tissue irritation at injection site
Sterile water	Solvent and vehicle	Dissolves active and inactive ingredients; maintains sterility
Preservatives (if multi-dose)	Antimicrobial protection	Prevents bacterial and fungal contamination in multi-dose vials

503A Pharmacy Standards and Quality Oversight

Compounded medications prepared by licensed 503A pharmacies are subject to USP (United States Pharmacopeia) standards for sterility, potency, and purity. These pharmacies must adhere to strict environmental controls, including cleanroom preparation, sterilization validation, and microbial testing. Quality oversight differs significantly from 503B facilities, which operate under FDA oversight as drug manufacturers.

PlexusDx exclusively partners with licensed 503A compounding pharmacies to ensure your semaglutide formulation meets these rigorous standards. Each pharmacy maintains records of ingredient sourcing, batch testing, and expiration dating. This transparency supports patient confidence and allows your healthcare provider to verify the preparation's quality credentials before you begin treatment.

Injectable vs. Oral Formulations: Composition Differences and Clinical Considerations

Compounded semaglutide is available in both injectable and oral forms, each with distinct composition profiles. Injectable semaglutide is aqueous and typically delivered as a sterile solution in pre-filled pens or vials. Oral semaglutide formulations use different excipients to enhance absorption across the gastrointestinal tract, often incorporating permeation enhancers and protective coatings.

Your healthcare provider considers bioavailability, injection site tolerability, and personal preference when recommending a formulation. Injectable compounded semaglutide achieves direct systemic delivery with predictable pharmacokinetics, while oral formulations may be preferred by patients seeking a non-injection option. Both undergo rigorous quality testing in licensed 503A settings, though their excipient compositions differ significantly.

Genetic Predispositions and Individual Response to Semaglutide Components

While all semaglutide formulations contain the same active ingredient, individual genetic variation in GLP-1 receptor pathways and related signaling molecules can influence treatment response patterns. Variants in the GLP1R gene, GIPR gene, and metabolic regulators like FTO and MC4R may provide context for understanding why some patients respond more robustly to semaglutide than others.

Understanding your genetic predispositions in peptide pathways does not predict exact medication response, but it can support a more informed conversation with your provider about whether compounded semaglutide is a suitable starting point or whether adjustment or alternative approaches may warrant discussion. PlexusDx's Precision Peptide Genetic Test reveals predispositions in these key pathways to help contextualize treatment decisions.

How PlexusDx Supports a More Personalized Approach

PlexusDx's commitment to transparent formulation composition stems from our belief that patients deserve to understand exactly what they are receiving. Our partnered 503A pharmacies source pharmaceutical-grade semaglutide and excipients from qualified suppliers, and we maintain clear documentation of ingredient sourcing and quality testing. This approach may help provide context for discussions with your healthcare provider about treatment safety and efficacy.

The Precision Peptide Genetic Test offered by PlexusDx reveals your predispositions in key GLP-1 receptor pathway genes GIPR signaling (rs1800437), and metabolic regulators (FTO rs9939609, MC4R rs17782313). These genetic insights can support understanding of how your body may process and respond to semaglutide's mechanism of action. The test does not guarantee exact medication response but should be interpreted with a qualified healthcare provider as part of a broader clinical assessment.

When evaluating compounded semaglutide composition and formulation type, consider sharing your genetic predisposition report with your provider. Together, you can discuss whether the injectable or oral formulation aligns with your genetic and clinical profile, expected response patterns based on pathway predispositions, and any adjustments to dosing or timing that may optimize outcomes. This personalized approach transforms generic ingredient information into actionable clinical strategy.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Microdose GLP-1 Protocol is $129/mo flat. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What is in a vial of compounded semaglutide besides the active ingredient?

The article lists sodium phosphate dibasic and monobasic as buffering agents, sodium chloride for osmolarity, and sterile water for injection as the solvent, with preservatives added in multi-dose presentations for antimicrobial protection. Each excipient has a stated job: holding pH, keeping the solution isotonic to prevent tissue irritation at the site, and maintaining sterility over shelf life.

What pH range is compounded semaglutide buffered to, and why does that matter?

The article says the sodium phosphate buffer maintains formulation pH between 7.0 and 7.4, a range it ties directly to injection safety. Buffering matters because both a peptide's stability and how an injection is tolerated depend on the solution sitting near physiological pH. The post presents this as a routine parameter a licensed 503A pharmacy controls for.

How close is semaglutide to the GLP-1 hormone the body makes on its own?

The article puts semaglutide at 94 percent amino acid sequence homology to native GLP-1, describing it as a modified human GLP-1 analog that is purified to pharmacopeial standards before compounding. That near-identity is why it activates the same receptors the body's own hormone acts on to regulate blood glucose, appetite signaling and gastric emptying.

What is the difference between a 503A pharmacy and a 503B facility?

The article describes 503A pharmacies as state-licensed compounders subject to USP standards for sterility, potency and purity, operating under cleanroom controls, sterilization validation and microbial testing. It distinguishes 503B facilities as operating under FDA oversight as drug manufacturers. PlexusDx states it partners exclusively with licensed 503A compounding pharmacies for its formulations.

Why do oral and injectable compounded semaglutide have different ingredient lists?

Because they face different absorption barriers. The article says injectable semaglutide is an aqueous sterile solution delivered directly into subcutaneous tissue, while oral formulations must survive and cross the gastrointestinal tract, so they incorporate permeation enhancers and protective coatings. It says both undergo quality testing in licensed 503A settings, but the excipient compositions differ significantly.

Related Reading

• Compounded Semaglutide 2
• Compounded Semaglutide
• Medvi Semaglutide
• Bioverse Semaglutide

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.